Proteomics International Laboratories Ltd (ASX:PIQ)
0.1450
-0.0050 (-3.33%)
May 12, 2026, 4:10 PM AEST
Proteomics International Laboratories Earnings Call Transcripts
Fiscal Year 2025
-
Four first-in-class diagnostic tests are being commercialized, with PromarkerD live in Australia and California and reimbursement pricing imminent. The company is focused on expanding launches, building strategic partnerships, and leveraging its digital platform, with no planned headcount increase for 2026.